Our History
Our History
Taking the road less traveled

Caplin Point has taken its products to different corners of the globe, catering predominantly to the “Bottom of the Pyramid” – underserved markets and populations – by offering high-quality, affordable products.
At Caplin, we are choice architects, who herald the belief that our choices and futures are defined and driven by our employees. The DNA of our Company is molded and informed by our past, with a laser focus on the future. This perception is what drives Caplin to continuously provide the highest quality healthcare products when the patient needs them and at a value that lifts underserved markets. We sought opportunities in spaces the broad market was not looking at, embraced the unknown and developed an insight into ways to succeed.

The Company’s visionary leadership has been conscious to create its own path. Caplin took on the mantle to cater to the healthcare needs of those at the “Bottom of the Pyramid” in the markets the Company operates.
The result of these learnings is that we did not just ensure the survival of our small company; we allowed it to flourish. We sought opportunities in spaces the broad market was not looking at, embraced the unknown and developed an insight into ways to further succeed.
Taking the road less traveled
Caplin Point has taken its products to different corners of the globe, catering predominantly to the “Bottom of the Pyramid” – underserved markets and populations – by offering high-quality, affordable products.
At Caplin, we are choice architects, who herald the belief that our choices and futures are defined and driven by our employees. The DNA of our Company is molded and informed by our past, with a laser focus on the future. This perception is what drives Caplin to continuously provide the highest quality healthcare products when the patient needs them and at a value that lifts underserved markets. We sought opportunities in spaces the broad market was not looking at, embraced the unknown and developed an insight into ways to succeed.
The Company’s visionary leadership has been conscious to create its own path. Caplin took on the mantle to cater to the healthcare needs of those at the “Bottom of the Pyramid” in the markets the Company operates.
The result of these learnings is that we did not just ensure the survival of our small company; we allowed it to flourish. We sought opportunities in spaces the broad market was not looking at, embraced the unknown and developed an insight into ways to further succeed.
Our Milestones
-
2011Oct 2011Started construction of Manufacturing Facility and R&D
-
2015Mar, 2015Successful completion of first EU-GMP audit.July, 2015Successful completion of first Brazil – ANVISA audit.
-
2016Successful completion of first US FDA audit.
-
2017Sept 2017First ANDA approved for a product developed and filed from Caplin.
-
2018Sept, 2018Successful completion of second US FDA audit.
-
2019Jan 2019Fidelity Inc’s Eight Roads And F-Prime Ventures Invests Into Caplin Steriles For Minority Stake.June 2019Successful Completion of third US FDA audit.
-
2020Dec 2020Capacity expansion including capabilities to manufacture Emulsions and Suspensions installed.
-
2021Line 2 & 3 Commissioning & Qualification
-
2022Line 4 Commissioning & Qualification
-
2023
- Line 5 and 6 Commissioning & Qualification
- Successful Completion of fourth US FDA Audit
- Successful Completion of INVIMA Audit
-
2024
- Successful Completion of fifth US FDA Audit.
- Successful completion of ANVISA Audit.
- Moving towards full Automation / Digitalization and Artificial Intelligence.